← Back to Search

Implant

Titanium vs Polymer Spinal Cages for Spinal Conditions

N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is scheduled to undergo combined interbody and posterolateral spinal fusion surgery using either the Medtronic Adaptix™ titanium cage or Medtronic CAPSTONE® PEEK cage in conjunction with a 50:50 mixture of local autograft and GRAFTON™ DBM DBF, and supplementation with a pedicle screw system
Subject has been unresponsive to conservative care for a minimum of 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Study Summary

This trial is comparing two types of cages used in a type of back surgery. One is made of titanium and the other is made of a polymer.

Who is the study for?
Adults over 18 needing lumbar fusion surgery for conditions like spondylolisthesis or degenerative disc disease, who've had no relief from 6 months of conservative care. Excludes those with prior lumbar surgery, certain medical conditions, obesity (BMI >45), infections, metal sensitivities, substance abuse history, pregnancy/lactation plans within a year, and involvement in litigation or other studies.Check my eligibility
What is being tested?
The trial compares two types of spinal fusion implants: Medtronic Adaptix™ titanium cage and CAPSTONE® PEEK cage. It aims to see which implant works better when used with local bone graft mix and pedicle screw systems in spine surgeries.See study design
What are the potential side effects?
Potential side effects may include reactions to the implant materials such as inflammation or infection at the site of surgery, pain or discomfort post-operation, allergic reactions to the titanium or PEEK material if sensitive, and complications related to bone healing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a specific spinal fusion surgery using Medtronic cages and GRAFTON™ mix.
Select...
My condition hasn't improved after 6 months of standard treatment.
Select...
I am over 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fusion rate at 6 months
Secondary outcome measures
Timing of fusion

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Medtronic Adaptix™ titanium implantsExperimental Treatment1 Intervention
This arm will use Medtronic Adaptix™ titanium implants supplemented with a pedicle screw system. Both cages will be used in conjunction with a 50:50 mixture of autograft: allograft using milled local autograft bone and GRAFTON™ DBM DBF (no iliac crest autograft will be utilized).
Group II: Medtronic CAPSTONE® PEEK cageActive Control1 Intervention
This arm will use Medtronic CAPSTONE® PEEK cage supplemented with a pedicle screw system. Both cages will be used in conjunction with a 50:50 mixture of autograft: allograft using milled local autograft bone and GRAFTON™ DBM DBF (no iliac crest autograft will be utilized).

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
829 Previous Clinical Trials
505,643 Total Patients Enrolled
4 Trials studying Spondylolisthesis
231 Patients Enrolled for Spondylolisthesis

Media Library

Medtronic Adaptix™ titanium implants (Implant) Clinical Trial Eligibility Overview. Trial Name: NCT05182489 — N/A
Spondylolisthesis Research Study Groups: Medtronic CAPSTONE® PEEK cage, Medtronic Adaptix™ titanium implants
Spondylolisthesis Clinical Trial 2023: Medtronic Adaptix™ titanium implants Highlights & Side Effects. Trial Name: NCT05182489 — N/A
Medtronic Adaptix™ titanium implants (Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05182489 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the sample size for this experiment?

"Affirmative, clinicaltrials.gov reflects that this scientific experiment is actively recruiting. The trail was initially shared on October 13th 2021 and subsequently updated January 6th 2022. 100 study participants are required from one healthcare facility."

Answered by AI

Are there currently any opportunities available for participants to join this trial?

"Correct. According to clinicaltrials.gov, the research began recruiting on October 13th 2021 and is still ongoing as of January 6 2022. The study requires 100 participants from one site."

Answered by AI
Recent research and studies
~19 spots leftby Nov 2024